Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Beam Therapeutics Inc. Banner

Beam Therapeutics Inc.

BEAM Stock Analysis

Page title

Section title

Breakdown
2017
2018
2019
2020
2021
2022
2023
Net Income
-8.002m-116.738m-78.326m-194.592m-370.638m-289.088m-132.527m
Depreciation & Amortization
11.000K650.000K3.503M4.735M7.451M14.147M20.012M
Change in Working Capital
740.000K10.075M-10.705m5.347M111.254M251.628M-116.455m
Operating Cash Flow
-2.707m-20.298m-72.003m-95.741m-66.268m22.527M-149.195m
Capital Expenditure
-346.000k-13.124m-12.518m-16.357m-46.811m-48.951m-33.732m
Free Cash Flow
-3.053m-33.422m-84.521m-112.098m-113.079m-26.424m-182.927m
Debt Repayment
0.0000.000-464.000k-1.698m-2.118m-2.287m-2.252m
Dividends Paid
0.0000.000-12.714m0.0000.0000.0000.000
Common Stock Issued
4.984M179.727M37.901M320.624M757.449M108.258M278.700M
Common Stock Repurchased
0.0000.000-25.187m0.0000.0000.0000.000
Net Change in Cash
1.931M146.005M-97.383m126.458M395.729M-327.219m203.128M